Definitive Contract 75N92021C00008
Award Date
4/2/21
Potential Completion Date
5/31/23
Potential Value
$24M
Federal Agency
National Heart Lung and Blood Institute
Awardee
Qorvo Biotechnologies LLC
Ultimate Awardee
Qorvo, Inc.
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bend, OR, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS) National Institutes of Health National Heart Lung and Blood Institute awarded a $5,253,450.00 firm fixed-price contract to Maxim Biomedical, Inc. to provide RADX TECH SARS-COV-2 antigen rapid tests. The contract has an estimated completion date of August 27, 2023 and was awarded on August 28, 2020. Maxim Biomedical is a small disadvantaged, woman-owned, Asian-Pacific American owned business that specializes in medical device manufacturing,...
The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute awarded Ellume USA LLC, a foreign-owned, self-certified small disadvantaged business, a $26,900,000 firm-fixed-price contract for the development of a point-of-care COVID-19 antigen test for the direct detection of the SARS-CoV-2 virus. This contract, part of the RADX-TECH program, has a completion date of March 29, 2023 and does not have a set-aside designation....
The National Institutes of Health awarded a $50.7 million firm fixed price modification to MicroGEM US Inc. under the RADX Tech Program. The modification extends an existing contract to maintain MicroGEM's production of 160,000 saliva-based, high-performing RT-PCR point-of-care cartridges and 1,000 portable devices per day for COVID-19 testing. The 25-minute tests and devices are non-invasive and portable. Funding comes from the Department of Health and Human Services National Institutes of...
The U.S. National Institute of Biomedical Imaging and Bioengineering, part of the Department of Health and Human Services, awarded a $16,239,965.00 firm fixed price contract to Mologic Inc., a foreign-owned for-profit organization, for the Rapid Acceleration of Diagnostics (RADx) Program Tech Project #7697: SARS-CoV-2 Antigen Home Test. This contract, which does not have a set-aside designation, aims to deliver the testing products through January 2025 from Mologic's facility in Bedford, New...
The Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute awarded a $22.57 million firm fixed price definitive contract to Flambeau Diagnostics LLC of Monona, Wisconsin. The contract is for the delivery of RADX TECH 2375 point-of-need, saliva-based COVID-19 testing platforms over a twenty-month period ending in March 2023. No subcontractors or set aside designations were indicated. The award supports the NIH's ongoing efforts to...
This is a firm-fixed-price purchase order awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Quanterix Corporation, a manufacturer of advanced biomarker detection technology. The $84,525 contract supports Quanterix's work on the Rapid Acceleration of Diagnostics (RADx) initiative for COVID-19 testing. Quanterix is providing specialized Simoa instruments, assay kits, and research services to federal agencies like the NIH,...
The Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute awarded a $250,000 firm fixed price purchase order to Arete Biosciences, LLC of Chicago, Illinois. The contract is to support the Rapid Acceleration of Diagnostics (RADX) Program Technology effort through January 18, 2022. No major subcontractors or set aside designations were indicated. The award provides funding for Arete Biosciences to likely deliver diagnostic technologies or...
This is a federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Detect Inc. for the Rapid Acceleration of Diagnostics (RADx) Tech II program. The contract is valued at $8,085,388.00 and has a firm fixed price pricing type. The contract is for the "Expanded Manufacturing and Commercialization of 'Detect' COVID-19 Test: Highly Scalable, Affordable, At-Home Rapid Test" project, with a completion date of October 13, 2022. This contract...
This contract was awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Luminostics Inc., a for-profit medical technology company. The $39,067,500.00 Firm Fixed Price contract is for the RADX-TECH program to develop and deliver a smartphone-based point-of-care test for rapid SARS-CoV-2 antigen detection from nasal swabs. This contract was not set aside for any particular business type. Luminostics has received prior federal contract and grant awards related to...
Princeton Biomeditech Corp was awarded a definitive, firm fixed price contract valued at $10,062,372.12 by the Department of Health and Human Services' National Institutes of Health National Heart, Lung and Blood Institute. The contract is for RADX TECH II PROJECTS 13356 & 13464, which involves developing and delivering a rapid, point-of-care multiplex assay and reader to simultaneously detect COVID-19 and influenza A & B antigens. Work will be performed in Monmouth Junction, New...